Heat-Map Visualization of Gas Chromatography-Mass Spectrometry Based Quantitative Signatures on Steroid Metabolism

Journal of the American Society for Mass Spectrometry

Volumn 20, Issue 9, 2009, Pages 1626-1637

  Moon, Ju Yeon ^a,b   Jung, Hyun Jin ^a,b   Moon, Myeong Hee ^b   Chung, Bong Chul ^a   Choi, Man Ho ^a  

^a Korea Institute of Science and Technology   (South Korea)

^b Yonsei University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BENIGN PROSTATIC HYPERPLASIA; DATA TRANSFORMATION; ENDOCRINE DISEASE; ENDOCRINE SYSTEMS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; METABOLIC CHANGES; OXIDOREDUCTASES; PROSTATE CELLS; QUANTITATIVE DATA; QUANTITATIVE EVALUATION; QUANTITATIVE RESULT; STEROID HORMONE; URINE SAMPLE;

CHROMATOGRAPHIC ANALYSIS; DATA VISUALIZATION; ENDOCRINOLOGY; ENZYMES; GAS CHROMATOGRAPHY; HORMONES; LIPIDS; MASS SPECTROMETERS; MASS SPECTROMETRY; METABOLISM; MINING; VISUALIZATION;

ENZYME ACTIVITY;

20ALPHA HYDROXYSTEROID DEHYDROGENASE; 3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; 3ALPHA HYDROXYSTEROID DEHYDROGENASE; ANDROGEN; CHOLESTEROL; CORTICOSTEROID; ESTROGEN; GESTAGEN; OXIDOREDUCTASE; STEROID 5ALPHA REDUCTASE; STEROID HORMONE; STEROL; TESTOSTERONE 17BETA DEHYDROGENASE;

ACCURACY; ADULT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GAS CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; PEPTIDE MAPPING; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; STEROID METABOLISM; STEROID URINE LEVEL; URINALYSIS;

ALGORITHMS; COMPUTER GRAPHICS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HOT TEMPERATURE; HUMANS; STEROIDS; URINALYSIS; USER-COMPUTER INTERFACE;

EID: 69549128022     PISSN: 10440305     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jasms.2009.04.020     Document Type: Article

References (41)

1. Nicholson J., Lindon J., and Holmes E. 'Metabonomics': Understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29 (1999) 1181-1189
2. Kaddurah-Daouk R., Kristal B.S., and Weinshilboum R.M. Metabolomics: a global biochemical approach to drug response and disease. Annu. Rev. Pharmacol. Toxicol. 48 (2008) 653-683
3. Dalle-Donne I., Rossi R., Colombo R., Giustarini D., and Milzani A. Biomarkers of oxidative damage in human disease. Clin. Chem. 52 (2006) 601-623
4. Lee S.H., Woo H.M., Jung B.H., Lee J.A., Kwon O.S., Pyo H.S., Choi M.H., and Chung B.C. Metabolomic approach to evaluate the toxicological effects of nonylphenol with rat urine. Anal. Chem. 79 (2007) 6102-6110
5. Falk R.T., Xu X., Keefer L., Veenstra T.D., and Ziegler R.G. A liquid chromatography-mass spectrometry method for the simultaneous measurement of 15 urinary estrogens and estrogen metabolites: assay reproducibility and interindividual variability. Cancer Epidemiol. Biomarkers Prev. 17 (2008) 3411-3418
6. Cho H.-J., Kim J.D., Lee W.-Y., Chung B.C., and Choi M.H. Quantitative metabolic profiling of 21 endogenous corticosteroids in urine by liquid chromatography-triple quadrupole-mass spectrometry. Anal. Chim. Acta 632 (2009) 101-108
7. Falkenstein E., Tillmann H.C., Christ M., Feuring M., and Wehling M. Multiple actions of steroid hormones-a focus on rapid, nongenomic effects. Pharmacol. Rev. 52 (2000) 513-555
8. Choi M.H., Hahm J.R., Jung B.H., and Chung B.C. Measurement of corticoids in the patients with clinical features indicative of mineralocorticoid excess. Clin. Chim. Acta 320 (2002) 95-99
9. Caulfield M.P., Lynn T., Gottschalk M.E., Jones K.L., Taylor N.F., Malunowicz E.M., Shackleton C.H.L., Reitz R.E., and Fisher D.A. The diagnosis of congenital adrenal hyperplasia in the newborn by gas chromatography/mass spectrometry analysis of random urine specimens. J. Clin. Endocrinol. Metabol. 87 (2002) 3682-3690
10. Choi M.H., Yoo Y.S., and Chung B.C. Biochemical roles of testosterone and epitestosterone to 5α-reductase as indicators of male-pattern baldness. J. Invest. Dermatol. 116 (2001) 57-61
11. Wong T., Shackleton C.H., Covey T.R., and Ellis G. Identification of the steroids in neonatal plasma that interfere with 17α-hydroxyprogesterone radioimmunoassays. Clin. Chem. 38 (1992) 1830-1837
12. Minutti C.Z., Lacey J.M., Magera M.J., Hahn S.H., McCann M., Schulze A., Cheillan D., Dorche C., Chace D.H., Lymp J.F., Zimmerman D., Rinaldo P., and Matern D. Steroid profiling by tandem mass spectrometry improves the positive predictive value of newborn screening for congenital adrenal hyperplasia. J. Clin. Endocrinol. Metabol. 89 (2004) 3687-3693
13. Nelson R.E., Grebe S.K., O'Kane D.J., and Singh R.J. Liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of estradiol and estrone in human plasma. Clin. Chem. 50 (2004) 373-384
14. Santen R.J., Demers L., Ohorodnik S., Settlage J., Langecker P., Blanchett D., Goss P.E., and Wang S. Superiority of gas chromatography/tandem mass spectrometry assay (GC/MS/MS) for estradiol for monitoring of aromatase inhibitor therapy. Steroids 72 (2007) 666-671
15. Hsing A.W., Stanczyk F.Z., Bélanger A., Schroeder P., Chang L., Falk R.T., and Feras T.R. Reproducibility of serum sex steroid assays in men by RIA and mass spectrometry. Cancer Epidemiol. Biomarkers. Prev. 16 (2007) 1004-1008
16. Wood L., Ducroq D.H., Fraser H.L., Gillingwater S., Evans C., Pickett A.J., Rees D.W., John R., and Turkes A. Measurement of urinary free cortisol by tandem mass spectrometry and comparison with results obtained by gas chromatography-mass spectrometry and two commercial immunoassays. Ann. Clin. Biochem. 45 (2008) 380-388
17. Palermo M., Gomez-Sanchez C., Roitman E., and Shackleton C.H.L. Quantitation of cortisol and related 3-oxo-4-ene steroids in urine using gas chromatography/mass spectrometry with stable isotope-labeled internal standards. Steroids 61 (1996) 583-589
18. Homma K., Hasegawa T., Masumoto M., Takeshita E., Watanabe K., Chiba H., Kurosawa T., Takahashi T., and Matsuo N. Reference values for urinary steroids in Japanese newborn infants: gas chromatography/mass spectrometry in selected ion monitoring. Endocrinol. J. 50 (2003) 783-792
19. Meffre D., Pianos A., Liere P., Eychenne B., Cambourg A., Schumacher M., Stein D.G., and Guennoun R. Steroid profiling in brain and plasma of male and pseudopregnant female rats after traumatic brain injury: analysis by gas chromatography/mass spectrometry. Endocrinology 148 (2007) 2505-2517
20. Moon J.-Y., Jung H.-J., Moon M.H., Chung B.C., and Choi M.H. Inclusion complex-based solid-phase extraction of steroidal compounds with entrapped beta-cyclodextrin polymer. Steroids 73 (2008) 1090-1097
21. Semmes O.J. Defining the role of mass spectrometry in cancer diagnostics. Cancer Epidemiol. Biomarkers Prev. 13 (2004) 1555-1557
22. Rhodes D.R., and Chinnaiyan A.M. Integrative analysis of the cancer transcriptome. Nat. Genet. 37 (2005) S31-S37
23. Ivshina A.V., Geroge J., Senko O., Mow B., Putti T.C., Smeds J., Lindahl T., Pawitan Y., Hall P., Nordgren H., Wong J.E.L., Liu E.T., Bergh J., Kuznetxov V.A., and Miller L.D. Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. Cancer Res. 66 (2006) 10292-10301
24. Ray S., Britschgi M., Herbert C., Takeda-Uchimura Y., Boxer A., Blennow K., Friedman L.F., Galasko D.R., Jutel M., Karydas A., Kaye J.A., Leszek J., Miller B.L., Minthon L., Quinn J.F., Rabinovici G.D., Robinson W.H., Sabbagh M.N., So Y.T., Sparks D.L., Tabaton M., Tinklenberg J., Yesavaga J.A., Tibschirani R., and Wyss-Coray T. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat. Med. 13 (2007) 1359-1362
25. Denkert C., Budczies J., Kind T., Weichert W., Tablack P., Sehouli J., Niesporek S., Konsgen D., Dietel M., and Fiehn O. Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors. Cancer Res. 66 (2006) 10795-10804
26. Dettmer K., Aronov P.A., and Hammock B.D. Mass spectrometry-based metabolomics. Mass Spectrom. Rev. 26 (2007) 51-78
27. Choi M.H., Kim J.N., and Chung B.C. Rapid HPLC-electrospray tandem mass spectrometric assay for urinary testosterone and dihydrotestosterone glucuronides from patients with benign prostate hyperplasia. Clin. Chem. 49 (2003) 322-325
28. McPherson S.J., Ellem S.J., Simpsn E.R., Patchev V., Fritzemeier K.-H., and Risbridger G.P. Essential role for estrogen receptor β in stromal-epithelial regulation of prostatic hyperplasia. Endocrinology 148 (2007) 566-574
29. Luu-The V., Bélanger A., and Labrie F. Androgen biosynthetic pathways in the human prostate. Best Pract. Res. Clin. Endocrinol. Metabol. 22 (2008) 207-221
30. Cho Y.-D., and Choi M.H. Alternative sample preparation techniques in gas chromatographic-mass spectrometric analysis of urinary androgenic steroids. Bull. Korean Chem. Soc. 27 (2006) 1315-1322
31. Husdan H., and Rapoport A. Estimation of creatinine by the Jaffe reaction. A comparison of three methods. Clin. Chem. 14 (1968) 222-238
32. Choi M.H., Kim K.-R., Hong J.K., Park S.J., and Chung B.C. Determination of nonsteroidal estrogens in breast milk, plasma, urine, and hair by gas chromatography/mass spectrometry. Rapid Commun. Mass. Spectrom. 16 (2002) 2221-2228
33. Reddy S., Iden C.R., and Brownawell B.J. Analysis of steroid conjugates in sewage influent and effluent by liquid chromatography-tandem mass spectrometry. Anal. Chem. 77 (2005) 7032-7038
34. Xu X., Veenstra T.D., Fox S.D., Roman J.M., Issaq H.J., Falk R., Saavedra J.E., Keefer L.K., and Ziegler R.G. Measuring fifteen endogenous estrogens simultaneously in human urine by high-performance liquid chromatography-mass spectrometry. Anal. Chem. 77 (2005) 6646-6654
35. Bolton J.L., and Thatcher G.R.J. Potential mechanisms of estrogen quinone carcinogenesis. Chem. Res. Toxicol. 21 (2008) 93-101
36. Wright F., Poizat R., Bongini M., Bozzolan F., Doukani A., and Mauvais-Jarvis P. Decreased urinary 5α-androstane-3α, 17 β-diol glucuronide excretion in patients with benign prostatic hyperplasia. J. Clin. Endocriol. Metabol. 60 (1985) 294-298
37. Bauman D.R., Steckelbroeck S., Peehl D.M., and Penning T.M. Transcript profiling of the androgen signal in normal prostate, benign prostatic hyperplasia, and prostate cancer. J. Clin. Endocriol. Metabol. 147 (2006) 5806-5816
38. Tsurusaki T., Aoki D., Kanetake H., Inoue S., Muramatsu M., Hishikawa Y., and Koji T. Zone-dependent expression of estrogen receptors &;α and β in human benign prostatic hyperplasia. J. Clin. Endocriol. Metabol. 88 (2003) 1333-1340
39. Prins G.S., and Korach K.S. The role of estrogens and estrogen receptors in normal prostate growth and disease. Steroids 73 (2008) 233-244
40. Martel C., Rhéaume E., Takahashi M., Trudel C., Couét J., Luu-The V., Simard J., and Labrie F. Distribution of 17 β-hydroxysteroid dehydrogenase gene expression and activity in rat and human tissues. J. Steroid Biochem. Mol. Biol. 41 (1992) 597-603
41. Délos S., Carsol J.-L., Fina F., Raynaud J.-P., and Martin P.-M. 5 α-Reductase and 17 β-hydroxysteroid dehydrogenase expression in epithelial cells from hyperplastic and malignant human prostate. Int. J. Cancer 75 (1998) 840-846